• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.

作者信息

van der Ven Roos G F M, van den Heuvel Teun B M, Rovers Koen P B, Nienhuijs Simon W, van Erning Felice N, de Hingh Ignace H J T

机构信息

Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.

Department of Health Services Research, Faculty of Health, Care and Public Health Research Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

出版信息

Ann Surg Oncol. 2024 Jun;31(6):3787-3788. doi: 10.1245/s10434-024-15193-0. Epub 2024 Mar 18.

DOI:10.1245/s10434-024-15193-0
PMID:38498087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11076309/
Abstract
摘要

相似文献

1
ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.ASO作者反思：解决基于医院的孤立性结直肠腹膜转移患者在接受细胞减灭术联合热灌注化疗（CRS-HIPEC）及生存方面的差异问题。
Ann Surg Oncol. 2024 Jun;31(6):3787-3788. doi: 10.1245/s10434-024-15193-0. Epub 2024 Mar 18.
2
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.旨在实现结直肠孤立性腹膜转移患者接受细胞减灭术联合腹腔热灌注化疗的平等机会和生存获益：一项全国范围内基于人群的研究。
Ann Surg Oncol. 2024 Jun;31(6):3758-3768. doi: 10.1245/s10434-024-15131-0. Epub 2024 Mar 7.
3
Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.对结直肠腹膜转移患者进行细胞减灭术和热灌注腹腔化疗的直接手术。
Eur J Surg Oncol. 2021 Nov;47(11):2865-2872. doi: 10.1016/j.ejso.2021.05.046. Epub 2021 Jun 3.
4
High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy.结直肠癌腹膜转移患者行细胞减灭术和腹腔热灌注化疗后，高等级术后并发症影响生存结局。
BMC Cancer. 2021 Jan 7;21(1):41. doi: 10.1186/s12885-020-07756-7.
5
Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgery.腹腔内热灌注化疗在不完全肿瘤细胞减灭术中的应用。
J Surg Oncol. 2022 Mar;125(4):703-711. doi: 10.1002/jso.26759. Epub 2021 Nov 29.
6
Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.结直肠腹膜转移患者经细胞减灭术和腹腔热灌注化疗治疗后孤立性腹膜复发的治疗。
Ann Surg Oncol. 2018 Jul;25(7):1992-2001. doi: 10.1245/s10434-018-6423-8. Epub 2018 Apr 18.
7
Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.重复细胞减灭术-腹腔内热灌注化疗在选择的腹膜转移患者中是可行的，并提供生存获益。
Ann Surg Oncol. 2019 May;26(5):1445-1453. doi: 10.1245/s10434-019-07218-w. Epub 2019 Mar 1.
8
ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).ASO作者反思：微卫星和RAS/RAF突变状态作为接受减瘤手术和腹腔内热灌注化疗（HIPEC）治疗的结直肠癌腹膜转移的预后因素
Ann Surg Oncol. 2022 Jun;29(6):3418-3419. doi: 10.1245/s10434-021-11057-z. Epub 2021 Nov 6.
9
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.结直肠和阑尾腹膜转移的细胞减灭术和腹腔热灌注化疗（HIPEC）-香港经验和文献复习。
Asian J Surg. 2021 Jan;44(1):221-228. doi: 10.1016/j.asjsur.2020.05.010. Epub 2020 Jun 27.
10
Should Cytoreductive Surgery Alone for Peritoneal Metastases of Colorectal Origin be Centralized? A National Study of 4159 Procedures.结直肠来源腹膜转移的细胞减灭术是否应集中进行？一项涉及 4159 例手术的全国性研究。
Ann Surg Oncol. 2024 Sep;31(9):6220-6227. doi: 10.1245/s10434-024-15180-5. Epub 2024 Mar 28.

本文引用的文献

1
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.旨在实现结直肠孤立性腹膜转移患者接受细胞减灭术联合腹腔热灌注化疗的平等机会和生存获益：一项全国范围内基于人群的研究。
Ann Surg Oncol. 2024 Jun;31(6):3758-3768. doi: 10.1245/s10434-024-15131-0. Epub 2024 Mar 7.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.结直肠癌患者同时性和异时性腹膜转移发生率的增加：一项全国性研究。
Eur J Surg Oncol. 2021 May;47(5):1026-1033. doi: 10.1016/j.ejso.2020.11.135. Epub 2020 Nov 26.
4
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts.结直肠癌患者热灌注腹腔化疗的患者选择：国际专家决策共识
Clin Colorectal Cancer. 2020 Dec;19(4):277-284. doi: 10.1016/j.clcc.2020.06.010. Epub 2020 Jul 15.
5
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study.结直肠腹膜转移患者的生存受诊断医院间治疗差异的影响：一项基于全国人群的研究。
Eur J Cancer. 2017 Apr;75:132-140. doi: 10.1016/j.ejca.2016.12.034. Epub 2017 Feb 20.